Thomas A Agbaedeng
Overview
Explore the profile of Thomas A Agbaedeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Agbaedeng T, Noubiap J, Roberts K, Chew D, Psaltis P, Amare A
Drugs
. 2024 May;
84(6):685-701.
PMID: 38809372
Background: Although dual antiplatelet therapy (DAPT) improves the outcomes of patients undergoing percutaneous coronary intervention (PCI), sex-specific differences in efficacy and safety of DAPT remain unresolved. We compared sex differences...
3.
Jiang J, Hiron T, Agbaedeng T, Malhotra Y, Drydale E, Bancroft J, et al.
Circ Res
. 2024 May;
135(1):6-25.
PMID: 38747151
Background: Coronary artery disease (CAD), the leading cause of death worldwide, is influenced by both environmental and genetic factors. Although over 250 genetic risk loci have been identified through genome-wide...
4.
Agbaedeng T, Iroga P, Rathnasekara V, Zacharia A
Obes Rev
. 2024 Jan;
25(4):e13684.
PMID: 38291816
Obesity is reported to increase stroke risk, with adipocyte-derived cytokines or adipokines implicated as mediators. However, the relationship between adipokines and stroke is not well clarified. Thus, we aimed to...
5.
Agbaedeng T, Roberts K, Colley L, Noubiap J, Oxborough D
Europace
. 2022 Mar;
24(10):1665-1674.
PMID: 35298614
Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle abnormality, is a major cause of sudden cardiac death (SCD). However, the burden of SCD and risk factors in ARVC...
6.
Agbaedeng T, Zacharia A, Iroga P, Rathnasekara V, Munawar D, Bursill C, et al.
Nutr Metab Cardiovasc Dis
. 2022 Mar;
32(4):853-862.
PMID: 35227548
Aims: Although overweight and obesity are associated with increased risk of atrial fibrillation (AF), the underlying mechanisms are not well characterised. Recent data suggest that this link may be partly...
7.
Noubiap J, Agbaedeng T, Nyaga U, Lau D, Worthley M, Nicholls S, et al.
J Cardiovasc Electrophysiol
. 2022 Jan;
33(3):414-422.
PMID: 34981859
Objective: To summarize data on the prevalence/incidence, risk factors and prognosis of atrial fibrillation (AF) in patients with acute coronary syndromes (ACS). Methods: MEDLINE, Embase, and Web of Science were...
8.
Noubiap J, Thomas G, Agbaedeng T, Fitzgerald J, Gallagher C, Middeldorp M, et al.
Eur Heart J Qual Care Clin Outcomes
. 2021 Dec;
8(8):852-860.
PMID: 34931671
Aims: This study aimed to investigate the impact of sex on the clinical profile, utilization of rhythm control therapies, cost of hospitalization, length of stay, and in-hospital mortality in patients...
9.
Emami M, Agbaedeng T, Thomas G, Middeldorp M, Thiyagarajah A, Wong C, et al.
Can J Cardiol
. 2021 Nov;
38(3):365-375.
PMID: 34822967
Background: Chronological aging is one of the major risk factors of cardiovascular (CV) disease (CVD); however, the effect of biological aging on CVD and outcomes remain poorly understood. Herein, we...
10.
Gawalko M, Agbaedeng T, Saljic A, Muller D, Wilck N, Schnabel R, et al.
Cardiovasc Res
. 2021 Sep;
118(11):2415-2427.
PMID: 34550344
Recent preclinical and observational cohort studies have implicated imbalances in gut microbiota composition as a contributor to atrial fibrillation (AF). The gut microbiota is a complex and dynamic ecosystem containing...